These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 26093659)

  • 21. Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis.
    Jones BE; Yang J; Muthigi A; Hogan SL; Hu Y; Starmer J; Henderson CD; Poulton CJ; Brant EJ; Pendergraft WF; Jennette JC; Falk RJ; Ciavatta DJ
    J Am Soc Nephrol; 2017 Apr; 28(4):1175-1187. PubMed ID: 27821628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic Modifications in ANCA-Associated Vasculitis: Potential for Insights into Disease Pathogenesis and Prediction of Outcome?
    Oates T; Salama AD
    J Am Soc Nephrol; 2017 Apr; 28(4):1011-1013. PubMed ID: 28049651
    [No Abstract]   [Full Text] [Related]  

  • 23. Unmet Needs in the Pathogenesis and Treatment of Vasculitides.
    Muratore F; Pazzola G; Soriano A; Pipitone N; Croci S; Bonacini M; Boiardi L; Salvarani C
    Clin Rev Allergy Immunol; 2018 Apr; 54(2):244-260. PubMed ID: 28895041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Harper L; Cockwell P; Adu D; Savage CO
    Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis.
    Franssen CF; Stegeman CA; Kallenberg CG; Gans RO; De Jong PE; Hoorntje SJ; Tervaert JW
    Kidney Int; 2000 Jun; 57(6):2195-206. PubMed ID: 10844589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New insights into the pathogenesis of ANCA-positive vasculitides].
    Guilpain P; Guillevin L; Mouthon L
    Presse Med; 2007 May; 36(5 Pt 2):854-9. PubMed ID: 17350787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Schreiber A; Kettritz R
    J Leukoc Biol; 2013 Oct; 94(4):623-31. PubMed ID: 23381471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic alterations underlying autoimmune diseases.
    Aslani S; Mahmoudi M; Karami J; Jamshidi AR; Malekshahi Z; Nicknam MH
    Autoimmunity; 2016; 49(2):69-83. PubMed ID: 26761426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic regulation in human melanoma: past and future.
    Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
    Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection.
    Villalta D; Tonutti E; Tampoia M; Bizzaro N; Papisch W; Tozzoli R; Stella S
    Clin Chem Lab Med; 2004; 42(10):1161-7. PubMed ID: 15552276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic and pathogenic significance of antineutrophil cytoplasmic antibodies in vasculitides].
    Bartůnková J; Tesar V; Fucíková T; Janatková I; Zabka J; Krystůfková O; Rychlík I
    Bratisl Lek Listy; 1995 Oct; 96(10):528-33. PubMed ID: 8620323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease.
    Gómez-Puerta JA; Hernández-Rodríguez J; López-Soto A; Bosch X
    Chest; 2009 Oct; 136(4):1101-1111. PubMed ID: 19809051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenomes as therapeutic targets.
    Hamm CA; Costa FF
    Pharmacol Ther; 2015 Jul; 151():72-86. PubMed ID: 25797698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetics in autoimmune diseases: Pathogenesis and prospects for therapy.
    Zhang Z; Zhang R
    Autoimmun Rev; 2015 Oct; 14(10):854-63. PubMed ID: 26026695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genetic risk factors for vasculitis].
    Holle JU; Gross WL
    Internist (Berl); 2014 Feb; 55(2):128-34. PubMed ID: 24217527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newer insights into the aetiology and pathogenesis of myeloperoxidase associated autoimmunity.
    Schmitt WH
    Jpn J Infect Dis; 2004 Oct; 57(5):S7-8. PubMed ID: 15507771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B cell epitope specificity in ANCA-associated vasculitis: does it matter?
    van der Geld YM; Stegeman CA; Kallenberg CG
    Clin Exp Immunol; 2004 Sep; 137(3):451-9. PubMed ID: 15320893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetics in the pathogenesis of systemic lupus erythematosus.
    Altorok N; Sawalha AH
    Curr Opin Rheumatol; 2013 Sep; 25(5):569-76. PubMed ID: 23846340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.